The Jackson Laboratory Receives NCI-MATCH Designation

December 9, 2019

JAX will contribute to cancer research through connecting eligible cancer patients with clinical trials for genetic treatment. The Jackson Laboratory recently announced that its Clinical Genomics Laboratory is participating in and contributing to the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) clinical trial. Being that JAX is a program affiliate, we have both an alumni and a current student in the picture posted to the Jackson Laboratory website! In the header photograph on this page we can see current Health Care Genetics student Melissa Soucy and alumni Dan Bergeron.